Sporadic late-onset nemaline myopathy: clinical, pathology and imaging findings in a single center cohort

Gabriella Silvestri, Massimiliano Mirabella, Enzo Ricci, Serenella Servidei, Mauro Monforte, Guido Alessandro Primiano, Marco Luigetti, Cristina Cuccagna, Giorgio Tasca

Risultato della ricerca: Contributo in rivistaArticolo in rivista

13 Citazioni (Scopus)

Abstract

Sporadic late-onset nemaline myopathy (SLONM) is a rare acquired myopathy characterized by rapid-onset proximal weakness in late adulthood, and the presence of nemaline bodies on muscle biopsy. In recent years, several therapeutic interventions, including immunomodulating agents and autologous stem cell transplantation, have shown variable degrees of efficacy in different patients, but no consensus has been reached to allow an effective tailoring of treatments in this severe disease. We performed a retrospective evaluation of clinical, pathological, laboratory, muscle MRI, and follow-up data of SLONM patients diagnosed in the period 2010–2015 in our neuromuscular center. Six patients (three males and three females) were identified. Average time elapsed from the onset of symptoms to referral to the neuromuscular specialist was 23.7 months. Monoclonal gammopathy was detectable in five patients. Nemaline bodies were detected in all the patients, and their abundance correlated with clinical severity. Signs of cardiac involvement were present in all the patients to different extents. Muscle MRI showed a preferential involvement of neck extensors, paraspinal, gluteal, hamstring and soleus muscles. All patients were treated with prednisone and repeated courses of intravenous immunoglobulins, and a favorable outcome was reached in five patients. Our experience confirms that SLONM is clinically characterized by subacute proximal and axial muscle weakness. Time to referral was relatively long and should be reduced with increasing awareness of the disease. Muscle MRI could be of help as a diagnostic tool to identify this potentially treatable myopathy. Cardiac evaluation should be warranted in all SLONM patients to detect subclinical heart involvement.
Lingua originaleEnglish
pagine (da-a)542-551
RivistaJournal of Neurology
Volume265
DOI
Stato di pubblicazionePubblicato - 2018

Keywords

  • Intravenous immunoglobulins
  • Late-onset myopathy
  • Monoclonal gammopathy
  • Muscle MRI
  • Nemaline rods

Fingerprint Entra nei temi di ricerca di 'Sporadic late-onset nemaline myopathy: clinical, pathology and imaging findings in a single center cohort'. Insieme formano una fingerprint unica.

Cita questo